Boye K - Search Results

1

Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour.

Hompland I, Bruland ØS, Ubhayasekhera K, Bergquist J, Boye K. Hompland I, et al. Among authors: boye k. Clin Sarcoma Res. 2016 Dec 15;6:21. doi: 10.1186/s13569-016-0062-2. eCollection 2016. Clin Sarcoma Res. 2016. PMID: 27999655 Free PMC article.

2

Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine.

Hølmebakk T, Bjerkehagen B, Boye K, Bruland Ø, Stoldt S, Sundby Hall K. Hølmebakk T, et al. Among authors: boye k. Br J Surg. 2016 May;103(6):684-691. doi: 10.1002/bjs.10104. Epub 2016 Mar 14. Br J Surg. 2016. PMID: 26988241

3

Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort.

Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K. Hompland I, et al. Among authors: boye k. Acta Oncol. 2017 Oct;56(10):1317-1323. doi: 10.1080/0284186X.2017.1330555. Epub 2017 May 30. Acta Oncol. 2017. PMID: 28557540

4

Genotype and risk of tumour rupture in gastrointestinal stromal tumour.

Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T. Boye K, et al. Br J Surg. 2018 Jan;105(2):e169-e175. doi: 10.1002/bjs.10743. Br J Surg. 2018. PMID: 29341147

5

Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study.

Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K. Hølmebakk T, et al. Among authors: boye k. Ann Surg Oncol. 2018 May;25(5):1133-1139. doi: 10.1245/s10434-018-6353-5. Epub 2018 Feb 12. Ann Surg Oncol. 2018. PMID: 29435684

6

Pazopanib in relapsed osteosarcoma patients: report on 15 cases.

Longhi A, Paioli A, Palmerini E, Cesari M, Abate ME, Setola E, Spinnato P, Donati D, Hompland I, Boye K. Longhi A, et al. Among authors: boye k. Acta Oncol. 2019 Jan;58(1):124-128. doi: 10.1080/0284186X.2018.1503714. Epub 2018 Sep 12. Acta Oncol. 2019. PMID: 30207179 No abstract available.

7

Multimodal kreftbehandling av gastrointestinal stromal tumor.

Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS. Hompland I, et al. Among authors: boye k. Tidsskr Nor Laegeforen. 2018 Oct 1;138(15). doi: 10.4045/tidsskr.18.0200. Print 2018 Oct 2. Tidsskr Nor Laegeforen. 2018. PMID: 30277049 Free article. Review. Norwegian.

8

Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour.

Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K. Hølmebakk T, et al. Among authors: boye k. Br J Surg. 2019 Mar;106(4):419-426. doi: 10.1002/bjs.11027. Epub 2018 Dec 3. Br J Surg. 2019. PMID: 30507040

9

Is Peritoneal Tumor Penetration of Prognostic Importance in Gastrointestinal Stromal Tumors?

Hølmebakk T, Bjerkehagen B, Lobmaier IVK, Hompland I, Stoldt S, Boye K. Hølmebakk T, et al. Among authors: boye k. Ann Surg Oncol. 2019 Dec;26(13):4730-4736. doi: 10.1245/s10434-019-07813-x. Epub 2019 Sep 13. Ann Surg Oncol. 2019. PMID: 31520212

10

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.

Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E. Boye K, et al. Cancer Immunol Immunother. 2021 Sep;70(9):2617-2624. doi: 10.1007/s00262-021-02876-w. Epub 2021 Feb 12. Cancer Immunol Immunother. 2021. PMID: 33580363 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page